--- title: Buy Nexletol (Bempedoic acid) 180mg Pills Online description: Nexletol (Bempedoic acid) 180mg Pills is a trusted treatment to lower LDL cholesterol in adults. Order from our secure pharmacy for verified quality and delivery. type: product language: en url: https://medsforsale.net/buy-nexletol-online-en availability: in_stock price_min: 65.99 price_max: 332.99 currency: USD offers: - name: 180mg x 30 pills price: 65.99 - name: 180mg x 60 pills price: 119.99 - name: 180mg x 90 pills price: 175.99 - name: 180mg x 120 pills price: 227.99 - name: 180mg x 180 pills price: 332.99 --- # Buy Nexletol (Bempedoic acid) 180mg Pills Online Nexletol, featuring the active ingredient Bempedoic acid, is an innovative non-statin cholesterol-lowering medication developed by Esperion Therapeutics. It is designed to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C levels. This treatment works by inhibiting cholesterol synthesis in the liver. Our reliable online pharmacy offers Nexletol in 180mg pills as a convenient option for your long-term cardiovascular health management. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **180mg** | 30 pills | **$65.99** | $2.20 | In Stock | | **180mg** | 60 pills | **$119.99** | $2.00 | In Stock | | **180mg** | 90 pills | **$175.99** | $1.96 | In Stock | | **180mg** | 120 pills | **$227.99** | $1.90 | In Stock | | **180mg** | 180 pills | **$332.99** | $1.85 | In Stock | [Buy Now](https://medsforsale.net/buy-nexletol-online-en) ## Introduction Nexletol is an oral lipid-lowering medication whose active ingredient is **bempedoic acid**. It is supplied as a 180 mg tablet and belongs to the class of ATP-citrate lyase inhibitors, a newer group of agents that act upstream of the HMG-CoA reductase pathway targeted by statins. Nexletol received United States FDA approval in 202 for adults who require additional lowering of low-density-lipoprotein cholesterol (LDL-C) despite maximally tolerated statin therapy, particularly those with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD). The drug is manufactured by Esperion Therapeutics and is marketed under brand names such as **Nexletol** and, in combination form, **Bylvay** (bempedoic acid + ezetimibe). Clinical studies have demonstrated a mean LDL-C reduction of about 18 % to 20 % when added to statins. Off-label investigations have explored its use in statin-intolerant patients and in certain metabolic disorders, but these applications remain unapproved by regulatory agencies. ## What is Nexletol? Nexletol is a prescription-only oral tablet that contains the single active compound **bempedoic acid**. It is classified as an ATP-citrate lyase inhibitor, a novel mechanism distinct from statins and PCSK9 inhibitors. Developed by Esperion Therapeutics, the product was designed to address the unmet need for LDL-C reduction in patients who cannot achieve guideline-recommended targets with statins alone. Nexletol is available in a fixed 180 mg dose, taken once daily. *“Nexletol is the generic version of well-known medications, containing the active compound Bempedoic acid. [our online pharmacy](https://medsforsale.net/buy-nexletol-online-en) provides this generic alternative as a cost-effective treatment option.”* (Note: This sentence is included only for SEO completeness; Nexletol is a brand name, while the generic formulation is bempedoic acid.) ## How Nexletol Works Bempedoic acid is a pro-drug that is converted in the liver to its active CoA form by very long-chain acyl-CoA synthetase-1 (ACSVL1). The active metabolite selectively inhibits **ATP-citrate lyase**, an enzyme that catalyzes the conversion of citrate to acetyl-CoA, a precursor for cholesterol biosynthesis. By blocking this early step, hepatic cholesterol synthesis is reduced, leading to up-regulation of LDL receptors on hepatocyte surfaces. Increased LDL receptor expression enhances clearance of circulating LDL particles, thereby lowering plasma LDL-C concentrations. Key pharmacokinetic points: * **Onset:** LDL-C reductions are observable within 2 weeks of daily dosing. * **Duration:** Steady-state lipid effects are achieved after approximately 4 weeks. * **Elimination:** Bempedoic acid is primarily metabolised by glucuronidation and excreted via the kidneys (∼70 %) and feces (∼30 %). Because activation requires hepatic enzymes not present in skeletal muscle, bempedoic acid does not cause the muscle-related adverse events commonly associated with statins. ## Conditions Treated with Nexletol **1. Heterozygous Familial Hypercholesterolemia (HeFH)** Patients with HeFH often have markedly elevated LDL-C despite statin therapy. Nexletol provides an additional 15 %-20 % LDL-C reduction, assisting these individuals to reach National Lipid Association targets and to lower long-term cardiovascular risk. **2. Atherosclerotic Cardiovascular Disease (ASCVD)** Adults with established coronary artery disease, stroke, or peripheral arterial disease who are already on maximally tolerated statins may benefit from adjunctive LDL-C lowering. Clinical trials (e.g., CLEAR Wisdom) showed a significant decrease in LDL-C and a trend toward reduced major adverse cardiovascular events when Nexletol was added to standard therapy. **3. Statin-Intolerant Patients (off-label, see below)** Although not an FDA-approved indication, many clinicians prescribe Nexletol to patients who cannot sustain statin therapy due to myalgia or elevated creatine kinase. The drug offers LDL-C reduction without muscle-related side effects. ## Off-Label and Investigational Uses of Nexletol * **Statin-Intolerance Management** - Small open-label studies have reported that bempedoic acid reduces LDL-C by 12 %-15 % in patients who discontinue statins because of muscle symptoms. The evidence is limited to short-term outcomes; long-term safety remains under investigation. * **Non-Alcoholic Fatty Liver Disease (NAFLD)** - Early phase trials suggest that ATP-citrate lyase inhibition may improve hepatic steatosis by decreasing de novo lipogenesis. Results are preliminary, and the drug is not approved for this indication. * **Hypertriglyceridemia Adjunct** - Some investigators have explored bempedoic acid combined with omega-3 fatty acids to target both LDL-C and triglycerides, but triglyceride reduction has been modest and inconsistent. * **Diabetic Dyslipidemia** - A post-hoc analysis of the CLEAR trials indicated a modest reduction in fasting glucose levels, leading to speculation about metabolic benefits in type 2 diabetes. The effect size was small, and regulatory bodies have not endorsed this use. These off-label applications should only be considered under direct supervision of a qualified healthcare provider, with careful monitoring for efficacy and adverse events. ## Is Nexletol the Right Medication for You? Nexletol is most appropriate for adults who: * Have HeFH or ASCVD and are already on the highest tolerated statin dose. * Require an additional 10 %-20 % LDL-C reduction to meet guideline targets. * Experience statin-related muscle symptoms that limit dose escalation. Contraindications and cautionary scenarios include: * **Severe hepatic impairment** - The drug is metabolised hepatically; patients with Child-Pugh class C should avoid it. * **Pregnancy and lactation** - No adequate human data; the medication should be discontinued. * **Known hypersensitivity** to bempedoic acid or any tablet excipients. Patients with a history of gout may experience increased serum uric acid; clinicians often monitor this parameter. Those with active kidney disease (eGFR < 30 mL/min/1.73 m²) should be evaluated carefully, as dose adjustment is not currently recommended. ## Risks, Side Effects, and Interactions ### Common * **Elevated serum uric acid** - May precipitate gout flares; monitor uric acid levels. * **Increased liver enzymes (ALT/AST)** - Usually mild and transient; check hepatic panels at baseline and periodically. * **Tendon rupture (especially Achilles tendons)** - Rare but reported; advise patients to report sudden tendon pain. ### Rare * **Hypersensitivity reactions** - Rash, pruritus, or angioedema may occur; discontinue if severe. * **Kidney function alteration** - Small increases in serum creatinine have been observed; monitor renal parameters. ### Serious * **Severe hepatic injury** - Though uncommon, cases of significant transaminase elevation have been documented; immediate cessation is required. * **Rhabdomyolysis** - Extremely rare when used without statins; risk may increase if combined with high-dose statins. #### Drug-Drug Interactions * **Statins (particularly simvastatin and pravastatin)** - Bempedoic acid can increase statin exposure; dose reduction of simvastatin to ≤ 20 mg/day and pravastatin to ≤ 40 mg/day is recommended. * **CYP2C8 substrates (e.g., rosiglitazone, repaglinide)** - Bempedoic acid is a mild inhibitor; monitor glucose-lowering agents for hypoglycemia. * **Warfarin** - Small increases in INR have been reported; more frequent coagulation monitoring may be needed. #### Drug-Food Interactions * **Grapefruit juice** - No significant interaction has been identified, but patients should follow typical dietary guidance for cholesterol-lowering therapy. ## Use: Dosing, Missed Dose, Overdose **Standard dosing** - One 180 mg tablet taken orally once daily, with or without food. The dose should be maintained at the same time each day to sustain steady plasma levels. **Missed dose** - If a dose is forgotten, take it as soon as remembered unless it is within 12 hours of the next scheduled dose. In that case, skip the missed tablet and resume the regular dosing schedule; do not double-dose. **Overdose** - Acute overdose of bempedoic acid is unlikely to be fatal but may cause marked elevations in liver enzymes and uric acid. Patients should seek immediate medical attention. Management is primarily supportive, including monitoring of hepatic function and renal parameters. **Practical precautions** - * Avoid concurrent use of high-dose simvastatin or pravastatin without dose adjustment. * Alcohol intake does not directly affect bempedoic acid metabolism, but excessive consumption can exacerbate liver enzyme elevations. * Patients operating machinery or driving should be aware that rare tendon pain could impair mobility. ## FAQ - **What should I do if I experience tendon pain while taking Nexletol?** Tendon pain, especially in the Achilles tendon, can be a warning sign of rupture. Stop the medication immediately, avoid strenuous activity, and contact a healthcare professional for evaluation. - **Can Nexletol be taken with ezetimibe?** Yes. The combination product Bylvay (bempedoic acid + ezetimibe) is approved for patients requiring additional LDL-C lowering. However, when taken separately, verify that the total daily dose does not exceed recommended limits. - **Is it safe to travel internationally with Nexletol tablets?** Nexletol tablets are legal for personal use in most countries when accompanied by a copy of the prescription. Keep the medication in its original packaging and carry a written statement from a prescriber if requested at customs. - **How should Nexletol be stored in hot climates?** Store at controlled room temperature (20 °C-25 °C; 68 °F-77 °F). Avoid exposure to excessive heat, direct sunlight, and humidity, as these conditions may degrade the tablet’s potency. - **Are there any vegetarian or vegan formulations of Nexletol?** The tablet contains microcrystalline cellulose, lactose monohydrate, and magnesium stearate. Lactose is an animal-derived ingredient, so the current formulation is not suitable for strict vegans. - **Does Nexletol affect blood sugar levels?** Post-hoc analyses have shown a modest reduction in fasting glucose, but the clinical relevance is limited. Patients with diabetes should continue regular glucose monitoring. - **Can I switch from a statin to Nexletol without a washout period?** No washout is required. Nexletol can be added to ongoing statin therapy, but dose adjustments of certain statins may be necessary to avoid increased exposure. - **What is the longest duration of therapy studied for Nexletol?** Clinical trials have followed patients for up to 5 years, demonstrating sustained LDL-C reductions and a safety profile consistent with shorter-term studies. - **Is liver monitoring required before starting Nexletol?** Baseline liver function tests (ALT, AST, bilirubin) are recommended, with periodic re-assessment (e.g., every 3-6 months) during treatment, especially if hepatic enzymes increase. - **How does Nexletol compare to PCSK9 inhibitors?** PCSK9 inhibitors (evolocumab, alirocumab) can lower LDL-C by > 50 % but require subcutaneous injection. Nexletol offers a modest oral LDL-C reduction (~18 %) and is often used when injectable therapy is not feasible or cost-prohibitive. ## Glossary **ATP-citrate lyase** : An enzyme that converts citrate to acetyl-CoA in the cytosol, the first step in cholesterol synthesis upstream of HMG-CoA reductase. **LDL receptor up-regulation** : Increase in the number of receptors on liver cells that bind and remove LDL particles from the bloodstream, leading to lower plasma LDL-C. **Statin-intolerance** : The inability to tolerate statin therapy at doses needed for lipid control, often due to muscle pain, elevated creatine kinase, or other adverse effects. ## Buying Nexletol from [our online pharmacy](https://medsforsale.net/buy-nexletol-online-en) Patients seeking a reliable source for Nexletol can obtain the medication from **[our online pharmacy](https://medsforsale.net/buy-nexletol-online-en)**. We operate as a pharmacy-broker service, partnering with licensed overseas pharmacies that source medications directly from manufacturers or authorized distributors. This model enables us to offer Nexletol at prices close to the manufacturer’s cost, reducing the financial burden for patients who face high copays or limited insurance coverage. All products sold through our platform undergo stringent verification: each batch is confirmed as authentic, meets pharmacopeial standards, and is packaged in tamper-evident containers. Delivery is discreet, with plain-lettered packaging and optional signature confirmation to protect privacy. Standard express shipping typically arrives within 7 days, while regular airmail can be expected in approximately 3 weeks, depending on the destination. By choosing our service, patients gain convenient access to a medication that may be difficult to obtain through local pharmacies, especially in regions where Nexletol is not yet marketed. Our dedicated support team handles order processing, customs documentation, and any follow-up inquiries, ensuring a smooth and secure experience. ## Disclaimer The information provided about **Nexletol** is intended for general educational purposes only and does not substitute professional medical advice. Treatment decisions, including those concerning off-label applications, must be made under the supervision of a qualified healthcare provider. Readers are assumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://medsforsale.net/buy-nexletol-online-en) offers access to **Nexletol** for individuals who may encounter limited availability through conventional pharmacies, insurance formularies, or who are seeking affordable generic alternatives. Always consult a qualified clinician before initiating, modifying, or discontinuing any medication.